The true impact of the French pay-for-performance program on physicians' benzodiazepines prescription behavior

摘要

Objectives The French pay-for-performance (P4P) contract CAPI implemented by the national health insurance included a target-goal which aims at reducing benzodiazepines prescriptions. In this investigation, we would like to assess whether: (1) the general practitioners (GPs) having signed P4P contract obtain better results regarding the target-goal than non-signatories; (2) (part of) this progression is due to the CAPI contract itself (tentative measurement of a "causal effect''); (3) (part of) the money spent on this P4P incentive can be self-financed with the amount of pharmaceuticals saved.